Product Description
Product Name: Atazanavir Sulphate and Ritonavir Tablets
Strength: Atazanavir 300 mg + Ritonavir 100 mg
Form: Oral Tablet
Category: Antiretroviral Combination (Protease Inhibitor with Pharmacokinetic Booster)
Indication: Human Immunodeficiency Virus (HIV-1) Infection
Atazanavir Sulphate and Ritonavir 300 mg/100 mg Tablets is a fixed-dose antiretroviral combination used in the management of HIV-1 infection. This regimen is administered as part of combination antiretroviral therapy (cART) and is intended for use in both treatment-naïve and treatment-experienced patients.
Atazanavir is a protease inhibitor that prevents HIV from maturing and multiplying, while Ritonavir acts as a pharmacokinetic enhancer, boosting the effectiveness of Atazanavir by inhibiting its metabolism, thereby increasing and prolonging its therapeutic levels in the bloodstream.
